Home Page

About Us

Investors

Inventors

Portfolio

Contact Us

Privacy Policy

Inventors - Norman D. Radtke, M.D.

Norman D. Radtke, M.D., Eyevation, LLC

   Norman D. Radtke, M.D., Eyevation, LLC

Norman Radtke, M.D., is founder and CEO of Eyevation, CEO of the Retina Vitreous Resource Center in Louisville and an adjunct professor of medicine at the University of Louisville.

Dr. Radtke's noted clinical expertise in retinal degenerative diseases is the foundation of Eyevation.

Dr. Radtke received his B.S. degree from the U.S. Naval Academy in Anapolis and his M.D. from UCLA. He completed his residency at the University of Florida before completing a retina fellowship at the University of Iowa and a vitreous fellowship at Duke University. He is published widely in peer-reviewed literature, including Ophthalmology and the American Journal of Ophthalmology.

He is certified by the American Board of Ophthalmology and is a Fellow of the American college of Surgeons. Dr. Radtke is internationally recognized for his research, teaching, and lecturing on vitreous surgery to ophthalmologists in the United States and abroad.







July 18, 2011
Louisville Will Host the 9th Annual MidAmerica Healthcare Venture Forum, November 8-9, 2011 (External Link)

October 15, 2010
Intrepid Featured on BioForm (PDF)

July 16, 2010
Intrepid Bioinformatics Receives Investment, Meets Milestones

May 6, 2010
MetaCyte Business Lab Receives Mention in Nature (PDF)

March 31, 2010
MetaCyte Recognized for Innovation

March 15, 2010
Teresa Leezer Honored a Second Time for Excellence in Business Management

February 23, 2010
Gailar Addresses Leaders as Part of Innovation Panel

January 2010
Triathlon Medical Ventures and the Kentucky Seed Capital Fund Lead Investment in Louisville Start-Up

November 2009
MetaCyte Advisor Bill Strench Featured in Business First (External Link)

November 2009
EndoProtech Awarded $270,000 from Kentucky Cabinet for Economic Development

August 25, 2009
Pierce Named Interim Head of UofL Research (External Link)

July 1, 2009
AllTranz Named Top Innovator by National Venture Group

May 8, 2009
ApoImmune Finalist for "Best Early-Stage Vaccine Biotech" at World Vaccine Congress ViE Awards

September 12, 2008
MetaCyte Team Shows Off New Offices

June 18, 2008
Teresa Leezer Honored by Cambridge Who's Who for Excellence in Business Management

Summer 2006
A UofL research team led by Fred Roisen, Ph.D., has developed a breakthrough adult stem-cell therapy that repairs spinal-cord damage in paralyzed rats (External Link)